Coenzyme-A Inc. (PPII)
Coenzyme-A Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Lynnwood, WA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $111. Its beta of 1.80 implies it has historically moved more than the broad market.
Coenzyme-A Inc. specializes in the development and manufacturing of nutraceutical supplements, alongside a comprehensive range of skincare and haircare products, which it distributes across the United States and internationally. Its extensive product portfolio includes vitality-boosting beverages and rejuvenating facial serums. The company also formulates solutions for weight management, various dermatological concerns, and the support of healthy fatty acid and cholesterol metabolism. Additionally, Coenzyme-A Inc. offers nutritional blends specifically designed to bolster bone, joint, ligament, cartilage, and connective tissue functions. Further expanding its offerings, the firm provides tailored supplements for sports performance, distinct formulas for women and men, and products focused on general wellness, energy enhancement, and body sculpting. Coenzyme-A Inc. was established in 1998 and is headquartered in Lynnwood, Washington.
Coenzyme-A Inc. is most often compared with the following Healthcare names: